ip Maguire welcomes second child as Man Utd skipper shares news with adorable post By www.mirror.co.uk Published On :: Sat, 9 May 2020 15:30:06 +0000 The England international defender became a father for the first time in April 2019 but his clan has now expanded after confirming partner Fern Hawkins had given birth again Full Article Sport
ip 5 Tech IPOs to Watch for in 2020 By sandhill.com Published On :: Fri, 24 Jan 2020 00:00:00 +0000 This year will likely bring far less unicorn hype, but tech firms with promising business models and profit outlooks could be poised for healthy IPOs in 2020. Keep on reading: 5 Tech IPOs to Watch for in 2020 Full Article
ip Top Social Media Tips for Execs By sandhill.com Published On :: Wed, 13 Jun 2018 00:00:00 +0000 The former Chief Digital Officer for New York City shares advice for how business leaders can best manage their personal media outlets. Keep on reading: Top Social Media Tips for Execs Full Article
ip M.R. Asks 3 Questions: Philippe Bouissou, Ph.D., Managing Partner, Blue Dots Partners LLC. By sandhill.com Published On :: Thu, 26 Mar 2020 00:00:00 +0000 For those of you who find yourselves with more time to read over the next few weeks, Managing Partner at Blue Dots Partners LLC., Philippe Bouissou, Ph.D., explains how his research and strategies help businesses stay aligned while working to survive a time of uncertainty. Keep on reading: M.R. Asks 3 Questions: Philippe Bouissou, Ph.D., Managing Partner, Blue Dots Partners LLC. Full Article
ip Rheumatoid Arthritis Triple Therapy Little Used in U.S. By www.medpagetoday.com Published On :: Fri, 08 May 2020 13:00:00 +0000 (MedPage Today) -- Triple therapy -- with methotrexate, hydroxychloroquine, and sulfasalazine -- is little used for the treatment of rheumatoid arthritis (RA) in the U.S. today, and clinical outcomes showed less efficacy than regimens combining... Full Article
ip NT's Nightcliff Tigers make NTFL history with back-to-back premierships By www.abc.net.au Published On :: Sun, 15 Mar 2020 11:21:00 +1100 Coronavirus concerns see low crowd numbers at the NT's NTFL grand final, where the Nightcliff Tigers make history winning back-to-back premierships in a first for the club, beating St Mary's by 13 points. Full Article Sport Australian Football League Community and Society
ip Melbourne City captures W-League championship with grand final win over Sydney FC By www.abc.net.au Published On :: Sat, 21 Mar 2020 17:30:28 +1100 The undefeated Melbourne City missed its supporters in the grandstand as a result of the coronavirus outbreak, but the W-League giant is celebrating another championship after beating Sydney FC 1-0 in the season decider. Full Article Soccer Sport
ip Farnan claims Golden Slipper triumph as spectators are locked out of Rosehill By www.abc.net.au Published On :: Sat, 21 Mar 2020 19:27:53 +1100 Hugh Bowman rides Farnan to victory in the prestigious Golden Slipper, as racegoers are barred from Rosehill Gardens in Sydney's west because of biosecurity protocols surrounding the coronavirus pandemic. Full Article Sport Horse Racing COVID-19
ip Dockers confirm AFLW premiership favouritism with massive win over Suns By www.abc.net.au Published On :: Sat, 21 Mar 2020 21:20:25 +1100 Fremantle shows why it is tipped to win its first AFLW flag with a 70-point thrashing of Gold Coast, as the Kangaroos and Demons also progress to the preliminary finals. Full Article Sport Australian Football League
ip Steve Smith leadership ban ends quietly amid coronavirus limbo By www.abc.net.au Published On :: Sun, 29 Mar 2020 15:57:59 +1100 Steve Smith is now free to captain Australia again if called upon, with the leadership ban arising from the ball-tampering scandal expiring quietly over the weekend. Full Article Infectious Diseases (Other) Respiratory Diseases COVID-19 Cricket Sport
ip Motorsport engineers use fix-it mentality to design equipment for fight against coronavirus By www.abc.net.au Published On :: Tue, 31 Mar 2020 16:38:16 +1100 From today, new masks and protective boxes are being shipped out to Australian medical staff to help protect them while treating coronavirus patients — and they're coming from an unlikely source. Full Article Infectious Diseases (Other) Respiratory Diseases COVID-19 Motor Sports Sport
ip AFL boss confirms membership refunds after McGuire and Jones on-air clash By www.abc.net.au Published On :: Thu, 02 Apr 2020 11:48:37 +1100 AFL chief executive Gillon McLachlan confirms club members can get their money back if they face financial hardship, but implores those who can afford it to stick with their clubs through the coronavirus pandemic. Full Article Sport COVID-19 Australian Football League
ip Rugby Australia is in serious trouble, with former Wallabies captains questioning current leadership By www.abc.net.au Published On :: Sun, 05 Apr 2020 10:13:35 +1000 Up to 15 former Wallabies captains unite to raise questions about the leadership of the current administration, with some predicting new management within a fortnight. Full Article COVID-19 Respiratory Diseases Infectious Diseases (Other) Sport Rugby Union
ip Tributes flow for former Richmond premiership player Michael Bowden By www.abc.net.au Published On :: Mon, 13 Apr 2020 13:46:47 +1000 Former Richmond Tigers premiership player Michael Bowden is remembered as a fierce footballer, inspiring educator and compassionate family man after his death from motor neurone disease at the age of 73. Full Article Sport Community and Society Australian Football League
ip Jordan told us we'll think he's a 'horrible guy' in his new documentary, but Scottie Pippen's come off worse so far By www.abc.net.au Published On :: Wed, 22 Apr 2020 04:50:47 +1000 After a concerted effort from #NBATwitter to bump up the release date of the Michael Jordan documentary The Last Dance, the first two episodes hit Netflix ahead of time on Monday night and we're already hooked. Full Article Basketball Sport Television Arts and Entertainment
ip Rugby Australia wants to meet ex-Wallabies skippers after receiving no-confidence letter By www.abc.net.au Published On :: Wed, 22 Apr 2020 10:04:16 +1000 Rugby Australia is prepared to hold crisis talks with a group of disgruntled retired Wallabies captains, who have penned a letter to the governing body claiming the game has "lost its way", while demanding a change in leadership. Full Article Rugby Union Super Rugby COVID-19 Sport
ip NRL players fined $1,000 for camping trip amid coronavirus lockdown By www.abc.net.au Published On :: Mon, 27 Apr 2020 11:22:00 +1000 NRL players Latrell Mitchell and Josh Addo-Carr have been fined $1,000 each for breaching the state's coronavirus distancing lockdown during a weekend away, as the NRL describes the getaway as "unacceptable". Full Article Sport NRL Health Disease Outbreak Diseases and Disorders Infectious Diseases (Other)
ip Dennis Rodman explodes onto scene as Jordan gets first chip in Netflix documentary series By www.abc.net.au Published On :: Tue, 28 Apr 2020 07:53:29 +1000 The latest instalment of The Last Dance shows us the Michael Jordan we know and love, as well as some outlandish antics from Dennis Rodman, including a team-sanctioned mid-season trip to Las Vegas. Full Article Basketball Sport
ip An AFL premiership won't define Dangerfield, but he is still desperate to win a flag By www.abc.net.au Published On :: Wed, 29 Apr 2020 15:52:13 +1000 He has claimed almost every individual honour there is in the AFL, but the highest goal continues to drive the Geelong star even during this uncertain 2020 season — a maiden premiership victory. Full Article Australian Football League Sport COVID-19
ip Multiple abuse claims from athletes but even wealthy sports yet to sign up to redress scheme By www.abc.net.au Published On :: Sun, 03 May 2020 07:15:55 +1000 Sporting organisations can afford to join the national redress scheme for institutional child sexual abuse but have chosen not to, according to government documents obtained by the ABC. Full Article Sport Community and Society Sport - Leisure Child Abuse Royal Commissions Law Crime and Justice
ip Add vavoom to your Zoom with 4 tips from Hollywood sound and lighting pros By www.latimes.com Published On :: Wed, 6 May 2020 14:28:41 -0400 Your Zoom or Skype meetings don't have to look like hostage videos. Here's what some experts advise. Full Article
ip Review: 'Spaceship Earth' is a captivating look back at Biosphere 2 and life in isolation By www.latimes.com Published On :: Thu, 7 May 2020 18:05:44 -0400 Matt Wolf's latest documentary, "Spaceship Earth," is a layered and absorbing account of a widely dismissed but remarkable scientific study. Full Article
ip End of the iPod: Goodbye to the little box that changed everything By www.thestar.com Published On :: Fri, 12 Sep 2014 08:00:00 EDT Full Article
ip Philippine nurses, long treated like exports, now told to stay home to fight coronavirus By www.latimes.com Published On :: Fri, 1 May 2020 21:32:56 -0400 The Philippines is promising better pay for its nurses to lure them to the front lines against COVID-19, but a legacy of exploitation and poor working conditions in the nation's hospitals has dampened the enthusiasm to answer the call. Full Article
ip Coronavirus: Sailors tell of months stuck on ships By www.bbc.co.uk Published On :: Tue, 05 May 2020 23:02:06 GMT Since March, many ports are refusing to allow crew changes or shore leave. Full Article
ip The Last Dance: 'I did not anticipate this reaction' By www.bbc.co.uk Published On :: Wed, 06 May 2020 17:18:20 GMT Jason Hehir speaks to the BBC about interviewing Michael Jordan and why the documentary series has had such an impact. Full Article
ip Wipro Acquires Appirio for $500,000,000 By www.sandhill.com Published On :: Sat, 22 Oct 2016 07:00:06 +0000 A global services provider, helping companies power their business with mobile, social and cloud technology from salesforce.com, Google, Workday and CSOD Full Article
ip Automating the Cloud: AWS Tools and Tips By sandhill.com Published On :: Fri, 07 Feb 2020 00:00:00 +0000 Sharing third-party AWS workflow options that can be integrated to increase your operation's effectiveness and productivity when working in the cloud. Keep on reading: Automating the Cloud: AWS Tools and Tips Full Article
ip Stanford Bioengineers Innovate Multiple Solutions to Tackle COVID-19 By feedproxy.google.com Published On :: Wed, 06 May 2020 18:28:43 +0000 The current pandemic is revealing the level of commitment needed from multiple sectors to deliver innovative solutions to tackle severe shortages of personal protective equipment, ventilators, and raw materials. Researchers at the Prakash lab at Stanford University are no stranger to taking up extreme challenges, and they have kept up their reputation by coming up […] Full Article Critical Care Materials Public Health
ip Packaging company ships over three million face shields to help with pandemic By www.medicalplasticsnews.com Published On :: Mon, 27 Apr 2020 10:31:42 -0000 Thermoformed packaging company Lacerta has managed to ship over three million Personal Protective Equipment (PPE) face shields to healthcare and frontline workers, in response to the coronavirus pandemic. Full Article
ip Greenlight Guru announces partnership to simplify global market access for medical device companies By www.medicalplasticsnews.com Published On :: Mon, 27 Apr 2020 14:00:00 -0000 Greenlight Guru, a Medical Device Quality Management Software (MDQMS) platform, has teamed up with Emergo by UL, a consulting firm specialising in global medical device regulatory compliance. Full Article
ip Formlabs receives FDA go-ahead to print BiPAP adapters By www.medicalplasticsnews.com Published On :: Mon, 04 May 2020 14:00:00 -0000 3D printing company Formlabs has received emergency use authorisation (EUA) from the U.S. Food and Drug Administration (FDA) to print bi-level positive airway pressure (BiPAP) adapters designed by Northwell Health, a New York healthcare provider. Full Article
ip Friday Feedback: Research on Lipid-Lowering Therapies 'Alive and Well' By www.medpagetoday.com Published On :: Fri, 27 Oct 2017 15:00:00 -0400 Experts discuss recent cancellation of first-in-class drug Full Article
ip USPTO Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting By patentlybiotech.wordpress.com Published On :: Wed, 01 Jun 2011 18:34:14 +0000 Biotechnology/Chemical/Pharmaceutical Customer Partnership Wednesday, June 8, 2011 Meeting Madison Auditorium Starting Time of 10:00 AM United States Patent and Trademark Office Alexandria, Virginia 600 Dulany Street, Alexandria, VA, Accessing the event: Double click on the link below (or copy it into your internet browser) https://uspto.connectsolutions.com/r80345544/ Click here for detailed login instructions in MS Word. […] Full Article Uncategorized BCP biotechnology Biotechnology Chemical Pharmaceutical Customer Partnership Meeting Clearing the Oldest Patent Applications (COPA) Expedited Examinations Green Tech Microsoft v. i4i Ltd. Patent Prosecution Highway Plant Utility Patents Track 1 USPTO
ip E&C Members Hold Bipartisan Teleconference Forum with CDC on Racial Disparities in COVID-19 Health Outcomes By energycommerce.house.gov Published On :: Fri, 01 May 2020 00:00:00 -0400 Members of the Energy and Commerce Committee’s Health and Oversight and Investigations subcommittees today held a bipartisan teleconference forum with Centers for Disease Control and Prevention (CDC) Principal Deputy Director Anne Schuchat, M.D., to discuss racial disparities in health outcomes for COVID-19 patients. Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), Health Subcommittee Ranking Member Michael C. Burgess, M.D. (R-TX), Oversight and Investigations Subcommittee Chair Diana DeGette (D-CO) and Oversight and Investigations Subcommittee Ranking Member Brett Guthrie (R-KY) released a joint statement following the call: “Today, bipartisan members of our two subcommittees discussed the deeply troubling racial disparities in health outcomes for COVID-19 patients with CDC’s Principal Deputy Director Schuchat. During the call, members received an update on CDC’s COVID-19 response, current data collection efforts, and reiterated the need for more accurate and timely demographic data. “Congress stands ready to work with the CDC to secure comprehensive demographic data to help us direct resources and support to close this gap in these health outcomes.” ### Full Article
ip Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses By xconomy.com Published On :: Fri, 01 May 2020 16:31:22 +0000 Lyra Therapeutics, a biotech company developing a new way to treat your persistently runny nose, has raised $56 million in its public markets debut. Late Thursday, Lyra offered 3.5 million shares priced at $16 apiece, which was the high end of its projected $14 to $16 price range. Those shares are expected to begin trading […] Full Article Boston Boston blog main Boston top stories National blog main 480 Biomedical Arsenal Medical Biotech Bob Langer chronic rhinosinusitis clinical trials COVID-19 deals Drug Delivery FDA Genzyme George Whitesides Inflammation investing IPO Keros Therapeutics Life Sciences Lyra Therapeutics Medical Device MIT mometasone furorate North Bridge Venture Partners ORIC Pharmaceuticals Perceptive Advisors Polaris Venture Partners Renaissance Capital startups Zentalis Pharmaceuticals
ip Kura Narrows Pipeline After Strategic Review Prompted by COVID-19 By xconomy.com Published On :: Wed, 06 May 2020 03:55:26 +0000 Kura Oncology is discontinuing development of one of its three clinical-stage cancer drug candidates amid pandemic-related impacts to its clinical trial plans. The decision to end work on the drug, KO-947, comes after San Diego-based Kura (NASDAQ: KURA) was successful in lifting a partial clinical hold placed on a Phase 1 trial of the drug […] Full Article National blog main San Diego San Diego blog main San Diego top stories Biotech cancer COVID-19 Drug Development Kura Oncology Life Sciences Syndax Pharmaceuticals Troy Wilson
ip Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs By xconomy.com Published On :: Fri, 08 May 2020 13:05:23 +0000 Ayala Pharmaceuticals has two clinical-stage cancer drugs licensed from Bristol Myers Squibb. Now it has $55 million to take those drugs further than the pharmaceutical giant did. On Thursday evening, Ayala priced its IPO, which consisted of 3.7 million shares sold for $15 each. That price was the midpoint of the targeted $14 to $16 […] Full Article National National blog main New York blog main New York top stories Acute Lymphoblastic Leukemia Adenoid Cystic Carcinoma Ayala Pharmaceuticals B-cell maturation antigen Biotech Bristol-myers Squibb clinical trials deals Desmoid tumors FDA investing IPO Israel Biotech Fund Life Sciences Novartis Pfizer SpringWorks Therapeutics triple-negative breast cancer
ip Biogen announces leadership updates By www.pharmafile.com Published On :: Wed, 02 Oct 2019 14:41:55 +0000 Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and Development in addition to his responsibilities as Chief Medical Officer. Additionally Alphonse Galdes has been appointed as Executive Vice President of Pharmaceutical Operations and Technology. In a statement, Michel Vounatsos, Chief Executive Officer at Biogen, said: “Both AI and Alphonse are seasoned and respected leaders at Biogen. Their accomplishment in the scientific community is well-recognised. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
ip Ipsen appoints new Exec VP and Chief Medical Officer By www.pharmafile.com Published On :: Fri, 17 Jan 2020 16:39:21 +0000 Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance. In his new role, which begins on 1 March 2020 and will be based in Paris, he will report directly to Ipsen CEO Aymeric Le Chatelier. His remit will include the provision of medical strategy to the company’s scientific, clinical and business teams, while also working in tandem with its R&D operations to design and direct clinical trials efforts to generation of post-launch data. read more Full Article appointment ipsen pharma Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
ip COVID-19 is a Perfect Storm of Hardship for US Immigrant Communities By blog.petrieflom.law.harvard.edu Published On :: Mon, 04 May 2020 12:00:05 +0000 Immigrant communities, along with communities of color and people experiencing existing health inequities, are expected to face disproportionate effects. The post COVID-19 is a Perfect Storm of Hardship for US Immigrant Communities appeared first on Bill of Health. Full Article Featured Health Law Policy Immigration Patient Care Public Health Race Social Determinants of Health coronavirus coronavirus pandemic COVID-19 COVID19 health disparities immigrants immigration and customs enforcement immigration status
ip Drug Channels News Roundup, March 2020: Sanofi’s Gross-to-Net Bubble, Drug Pricing Findings, Amazon Replaces Express Scripts, and Drug Channels Video By feeds.feedblitz.com Published On :: Tue, 31 Mar 2020 11:30:00 +0000 First, let me say thank you to all of the healthcare workers who are putting themselves at risk during this crisis.As I noted last week, many of the crucial issues for our healthcare system will remain after we all get through this challenging period. In that regard, here’s a look at some noteworthy news from the past month: Sanofi discloses new data about insulin pricesExcellent new academic research on list vs. net drug prices Three notable researchers overturn their earlier research on drug costsAmazon switches PBM vendors for some of its employeesPlus, we unveil the teaser trailer for Drug Channels Video!P.S. Join the more than 9,000 followers of my daily links to neat stuff at @DrugChannels on Twitter. My recent tweets have highlighted such topics as:How GoodRx shares patients’ prescription data2019 drug trend at Prime TherapeuticsControversy about the independent pharmacy marketA new $5 generic mail order program, Medicare Part D reformRetail pharmacy’s futureJob openings at Amazon Frozen cookie doughAnd much more!I have also been tweeting many under-the-radar stories about how the coronavirus affects drug channels.Read more » Full Article Benefit Design Costs/Reimbursement Gross-to-Net Bubble PBMs
ip Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal (rerun) By feeds.feedblitz.com Published On :: Tue, 05 May 2020 11:30:00 +0000 This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers. I suspect this deal will remain profitable for the participating companies even as COVID-19 alters the US. prescription payer mix. Click here to see the original post and comments from January 2020. National market shares for the largest PBMs in 2019 appears as Exhibit 88 of our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.P.S. Sorry that today's meme is one day too late for Star Wars day.Just before the holidays, Cigna’s Express Scripts business announced a market-changing deal with Prime Therapeutics. Click here to read the press release.There's been very little written about this transaction, though it has potentially major implications. Below, I share my thoughts on the following topics arising from the deal:Implications for manufacturers and pharmaciesThe role of the secretive Ascent Health Services What this all means for WalgreensWhy the Federal Trade Commission won’t challenge the dealA few weeks ago, I explained why integrated insurer / PBM / specialty pharmacy / provider organizations are poised to restructure U.S. drug channels. The Express Scripts / Prime deal signals that the channel will continue its amazing pace of reinvention.The scale, scope, and interconnectedness of today’s market participants make the system increasingly resistant to massive disruption from either external players like Amazon or a government takeover. Like it or not, the channel will continue to gain power and extract profit. Read on and see if you agree.Read more » Full Article Channel Management Group Purchasing Organizations (GPOs) Industry Trends Mergers and Acquisitions PBMs
ip Express Scripts vs. CVS Health: Five Lessons From the 2020 Formulary Exclusions and Some Thoughts on Patient Impact (rerun) By feeds.feedblitz.com Published On :: Thu, 07 May 2020 11:30:00 +0000 This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers. Today's rerun highlights one of the most effective tactics that PBMs have developed to extract deeper discounts from brand-name drug makers. COVID-19 seems likely shift the U.S. payer mix away from commercial health plans. Expect even tighter formulary management and more restrictions as PBMs work even harder to cut costs for their plan sponsor clients. Click here to see the original post and comments from January 2020.For 2020, the two largest pharmacy benefit managers (PBMs)—Express Scripts and the Caremark business of CVS Health—have again increased the number of drugs they have excluded from their standard formularies. The 2020 formulary exclusion lists are available below for your downloading pleasure.Below, I highlight my key takeaways from the 2020 lists:The number of exclusionsManagement of specialty drugsIndication-based formulariesThe slow adoption of biosimilarsThe PBMs’ patient-unfriendly exclusions in the hepatitis C categoryFormulary exclusions have emerged as a powerful tool for PBMs to gain additional negotiating leverage against manufacturers. The prospect of exclusion leads manufacturers to offer deeper rebates to avoid being cut from the formulary. Exclusions are therefore a key factor behind falling brand-name net drug prices.Read on for a look at this year’s exclusions along with some closing thoughts on what exclusions mean for patients.Read more » Full Article Benefit Design Biosimilars PBMs Specialty Drugs
ip Majority of Americans Open to Clinical Trial Participation If Recommended by a Doctor, New Study Finds By www.acrohealth.org Published On :: Wed, 06 Sep 2017 17:35:42 +0000 WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) applauds Research!America for a recently released survey on the public’s perception of clinical trials.... Full Article News Press Releases
ip ACRO expands membership with addition of three digital technology companies By www.acrohealth.org Published On :: Mon, 15 Apr 2019 15:54:16 +0000 The Association of Clinical Research Organizations (ACRO) is pleased to announce the expansion of its membership to include ERT, Oracle and Veeva. These new ACRO member companies, with their focus on digital technologies that enable global clinical trials, characterize the ongoing innovation and evolution of contemporary clinical research. ACRO now has 12 member companies. Full Article News Press Releases ERT IQVIA membership Oracle Veeva
ip Methadone to be supplied without new prescription during Covid-19 crisis By www.theguardian.com Published On :: 2020-04-08T05:00:08Z Pharmacists will be allowed to give out medication to patients who have already been receiving itPharmacists are to be allowed to hand out a range of super-strength medicines, including the heroin substitute methadone, without prescription during the Covid-19 crisis, under emergency measures that official drug policy advisers have warned could trigger a spike in drug misuse.The Advisory Council for Misuse of Drugs (ACMD), which makes recommendations to the government on the control of dangerous drugs, was asked by the home secretary to consider the risks of lifting restrictions on certain substances controlled under the Misuse of Drugs Act. Continue reading... Full Article Drugs policy UK news Pharmaceuticals industry Drugs Coronavirus outbreak Politics Science Society
ip Novartis’ asthma triple heads CHMP’s latest meeting By www.pmlive.com Published On :: Tue, 05 May 2020 12:50:48 +0100 Eight new medicines recommended for approval Full Article
ip India remains on USTR list of IP problem countries By www.thepharmaletter.com Published On :: Mon, 04 May 2020 16:58:00 +0100 India continues to be on the 'Priority Watch List' of the US Trade Representative (USTR) for lack of… Full Article Focus On/Generics/India/Intellectual property law/Legal/Patents & Trademarks/USA
ip US-Swiss partnership takes aim at rare heart condition By www.thepharmaletter.com Published On :: Mon, 04 May 2020 17:15:00 +0100 A new collaboration targeting rare heart diseases has been formed between California’s BioMarin Pharmaceutical… Full Article BioMarin Pharmaceutical/Biotechnology/Cardio-vascular/Deals/DiNA-001/DiNAQOR/Licensing/Rare diseases/Research/Switzerland/USA